miscsubjectsAI governance
Evidence review

TB-500 for Post-Surgery: Evidence-Graded Look at Repair-Cell Migration Pathways

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-post-surgery`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-post-surgery

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-post-surgery/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-post-surgery/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-post-surgery/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-post-surgery/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • TB-500 → inflammation clearance / repair-cell migration

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.37 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Thymosin beta4 accelerates wound healing (source s1)

1999 rat study demonstrating accelerated wound healing with thymosin beta-4.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Thymosin beta4 eye drops for dry eye (source s2)

Phase 2 human trial results cited across multiple secondary sources.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Phase 1 safety of recombinant thymosin beta-4 (source s3)

Safety data from 84-subject human trial.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Reddit ACL recovery thread mentioning TB-500 — Reddit, r/ACL (source s5)

Example user report from post-surgical context.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Post-surgery recovery · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain 4944a23545d7 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
preclinical
A 1999 rat study found thymosin beta-4 accelerated full-thickness wound healing and angiogenesis.
sources: s1
humanlow confidence
A 2015 phase 2 human trial of thymosin beta-4 eye drops showed 35% reduction in ocular discomfort and 59% reduction in corneal staining vs placebo at day 56.
sources: s2
humanlow confidence
A 2021 phase 1 safety study in 84 healthy volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events.
sources: s3
anecdotallow confidence
Reddit users post-ACL and rotator cuff surgery commonly report perceived faster swelling reduction and mobility gains with TB-500 alongside rehab.
sources: s5
Low-confidence / auto-generated 1
speculative0.10low confidence
A 2026 scoping review of 80 studies concluded human evidence is concentrated in ocular/dermal settings with limited direct TB-500 musculoskeletal data.
grok/grok-4.3
Grades the overall evidence distribution separating human from preclinical.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:32
TB-500 for Post-Surgery: Evidence-Graded Look at Repair-Cell Migration Pathways · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Post Surgery
Slug: tb-500-post-surgery
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenera
it output
{
  "slug": "tb-500-post-surgery",
  "title": "TB-500 for Post-Surgery: Evidence-Graded Look at Repair-Cell Migration Pathways",
  "body": "## What's breaking down\n\nAfter surgery, tissue layers face mechanical disruption, bleeding, and an inflammatory response. Repair cells must migrate to the wound site, reorganize the actin cytoskeleton for movement, clear debris, and lay down new matrix. If cell migration stalls or inflammation lingers, healing slows and scar tissue can form instead of functional repair. Post-surgical recovery hinges on whether regeneration outpaces ongoing breakdown at the incision or repair site.\n\n## Why TB-500 might help you\n\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nTB-500 is a fragment studied to mimic parts of the natural thymosin beta-4 protein. In post-surgery contexts, the focus stays on helping cells reach the surgical site faster and supporting organized rebuilding rather than suppressing the overall healing signal.\n\n## How these fit together\n\nSingle-
be4498f18c03911e
Machine verification: /api/articles/tb-500-post-surgery/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "A 1999 rat study found thymosin beta-4 accelerated full-thickness wound healing and angiogenesis."?
ask tb-500-post-surgery claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "A 2015 phase 2 human trial of thymosin beta-4 eye drops showed 35% reduction in ocular discomfort and 59% reduction in corneal staining vs p…"?
ask tb-500-post-surgery claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "A 2021 phase 1 safety study in 84 healthy volunteers found recombinant thymosin beta-4 well tolerated with no serious adverse events."?
ask tb-500-post-surgery claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users post-ACL and rotator cuff surgery commonly report perceived faster swelling reduction and mobility gains with TB-500 alongside …"?
ask tb-500-post-surgery claim c5 · paste includes §SELF
What does the ledger say about this (speculative tier): "A 2026 scoping review of 80 studies concluded human evidence is concentrated in ocular/dermal settings with limited direct TB-500 musculoske…"?
ask tb-500-post-surgery claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Example user report from post-surgical context."
ask tb-500-post-surgery source s5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Post-Surgery: Evidence-Graded Look at Repair-Cell Migration Pathways — and what would you need me to tell you first?
ask tb-500-post-surgery condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for Post-Surgery: Evidence-Graded Look at Repair-Cell Migration Pathways (studies vs anecdotes)?
ask tb-500-post-surgery good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…